Janus Global Life Sciences Fund (JAGLX)
Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 4/17/15 )$61.83
Total Net Assets (As of 3/31/15)$4.31B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.93%
NET 0.93%

Performance (As of 3/31/15)
1 Year42.40%
3 Year37.04%
5 Year26.97%
10 Year15.75%
Morningstar (As of 3/31/15)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

120 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Data as of 3/31/15. Index represents the MSCI World Health Care Index.

TOP HOLDINGS (% of Fund)

Johnson & Johnson 3.00
Amgen, Inc. 2.84
Biogen, Inc. 2.73
Actavis PLC 2.43
Valeant Pharmaceuticals International, Inc. (U.S. Shares) 2.39
AbbVie, Inc. 2.24
Celgene Corp. 2.16
Roche Holding AG 2.16
Boston Scientific Corp. 1.97
Pharmacyclics, Inc. 1.91
TOTAL23.83

CHARACTERISTICS

Number of Holdings
Equity Issues

94
Market Capitalization
Weighted Average
Median

$55.69B
$23.56B
Portfolio Turnover Ratio
(1-year trailing)

44.75%
Price/Earnings Ratio
(1-year forward)

21.30
Price/Book Ratio
(1-year forward)

8.20
Earnings Growth Rate
(1-year forward)

11.47%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
Pharmacyclics, Inc.
Auspex Pharmaceuticals, Inc.
Receptos, Inc.
Catamaran Corp. (U.S. Shares)
Novo Nordisk A/S - Class B
DETRACTORS
OvaScience, Inc.
Genfit
Pacira Pharmaceuticals, Inc.
Juno Therapeutics, Inc.
Achillion Pharmaceuticals, Inc.

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 95.99 100.00
 
 
Consumer Staples 1.05 -
 
Financials 1.01 -
 
Cash & Equivalents 1.36 -
 
Restricted Cash 0.59 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 76.71 65.06
Non-U.S. Developed 20.34 34.94
Non-U.S. Emerging 1.00 -
Restricted Cash 0.59 -
Cash & Equivalents 1.36 -

REGIONS (%)

FUNDINDEX
North America 80.81 66.74
Europe 14.43 26.38
Africa/Mideast 1.81 1.21
Asia/Pacific Ex Japan 1.00 1.23
Cash & Equivalents 1.36 -
Restricted Cash 0.59 -

COUNTRIES (%)

FUNDINDEX
United States 76.72 65.07
Switzerland 4.51 10.00
Canada 4.10 1.68
United Kingdom 3.27 5.82
France 2.42 3.16
Israel 1.81 1.21
Denmark 1.78 2.63
Germany 1.27 4.18
China 1.00 -
Sweden 0.92 0.18
Netherlands 0.25 -
Cash & Equivalents 1.36 -
Restricted Cash 0.59 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 20.41 50.50
$50 Billion to $100 Billion 16.86 17.90
$10 Billion to $50 Billion 31.68 28.10
$5 Billion to $10 Billion 7.32 2.82
$1 Billion to $5 Billion 19.01 0.68
$500 Million to $1 Billion 3.42 -
N/A 1.30 -

TOP INDUSTRIES (%)

FUNDINDEX
Pharmaceuticals 38.88 55.98
Biotechnology 33.67 15.38
Health Care Equipment 8.64 10.63
Health Care Services 5.62 3.81
Health Care Distributors 2.31 2.93
Health Care Facilities 1.93 1.01
Managed Health Care 1.69 5.67
Health Care Technology 1.43 0.60
Life Sciences Tools & Services 1.20 2.92
Insurance Brokers 1.01 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.